NASDAQ · Medical - Devices

Cutera, Inc. (CUTR) Stock

$0.10 +0.00% NASDAQ: CUTR Healthcare

Cutera, Inc. is a medical technology enterprise specializing in the research, development, manufacturing, marketing, and servicing of cutting-edge laser and energy-based aesthetic systems for medical professionals worldwide.

Valuation

MetricValue
Price$0.10
Market Cap$1.96M
P/E Ratio-0.01
P/B Ratio-0.01
P/S Ratio0.01
EPS (TTM)$-8.19
52-Week High$3.00
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE174.14%
ROA-47.02%
ROCE-60.43%
Gross Margin19.54%
Operating Margin-73.57%
Net Margin-76.67%
Debt/Equity-2.51
Current Ratio3.07

Annual Financials (USD)

Metric20192020202120222023
Revenue$182.0M$148.0M$231.0M$252.0M$212.0M
Operating Profit$-12.0M$-23.0M$-1.0M$-38.0M$-156.0M
Net Profit$-12.0M$-24.0M$2.0M$-82.0M$-163.0M
EPS$-0.88$-1.43$0.11$-4.39$-8.19
Op Margin-6.6%-15.5%-0.6%-15.1%-73.6%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$114.0M$133.0M$280.0M$521.0M$346.0M
Total Liabilities$68.0M$76.0M$224.0M$536.0M$518.0M
Cash$26.0M$47.0M$164.0M$146.0M$144.0M
Borrowings$8.0M$25.0M$150.0M$431.0M$432.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-2.0M$-17.0M$1.0M$-67.0M$-138.0M
Investing Cash Flow$2.0M$13.0M$-2.0M$-217.0M$275.0M
Financing Cash Flow$1.0M$-4.0M$-23.0M$-73.0M$-5.0M
Net Cash Flow$0$21.0M$118.0M$-18.0M$-3.0M
Free Cash Flow$-3.0M$-18.0M$0$-90.0M$-171.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.06
FCF Yield-8736.13%
Quick Ratio2.35
Interest Coverage-11.15
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CMAXCareMax, Inc. $0.42 +100.00% 0.00 $1.61M 0.00%
FRESFresh2 Group Limited $0.85 -23.42% 0.00 $2.08M 0.00%
GMVDG Medical Innovations Holdings Ltd $0.18 +1.38% 0.00 $1.80M 0.00%
HIND $2.17 +0.23% -0.44 $15.23M 0.00%
MTPMidatech Pharma plc $0.29 -18.50% -0.02 $1.98M 0.00%

About Cutera, Inc.

Cutera, Inc. is a medical technology enterprise specializing in the research, development, manufacturing, marketing, and servicing of cutting-edge laser and energy-based aesthetic systems for medical professionals worldwide. The company's comprehensive product line includes several advanced devices: Secret PRO, an innovative system combining fractional CO2 technology for thorough skin resurfacing with radio frequency (RF) microneedling for deep dermal tissue restructuring. truSculpt flex, a bio-electrical muscle stimulation apparatus engineered to support individuals across all fitness capabilities. excel V+, a versatile platform designed for addressing vascular and benign pigmented lesions. truSculpt iD, specifically tailored for the non-invasive body contouring sector. Secret RF, a fractional RF microneedling system that promotes precise tissue coagulation and hemostasis. Cutera also provides robust multi-application platforms: The enlighten platform, a laser system highly effective for tattoo removal, as well as treating benign pigmented lesions and acne scarring. The excel HR platform, offering an extensive hair removal solution compatible with diverse skin types. The xeo platform, a adaptable system where users can acquire various handpiece attachments to manage unwanted hair, treat vascular lesions, and achieve overall skin revitalization by targeting discoloration, fine lines, and laxity. In addition to its device offerings, Cutera distributes a range of skincare products and delivers post-warranty support, accessible via extended service agreements or direct billing. The company supplies specialized pulsed light handpieces for treating discoloration, facilitating hair removal, and managing vascular conditions. It further offers Pearl and Pearl Fractional handpieces, along with essential consumables such as handpiece refills, cycle refills, consumable tips, and marketing materials, all available for purchase through its official website. Cutera's products are marketed and sold through a direct sales team, reaching a wide spectrum of medical and aesthetic professionals. This includes plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, other certified practitioners, and even medical doctors performing aesthetic procedures in non-clinical environments. Founded in 1988, Cutera, Inc. maintains its corporate headquarters in Brisbane, California.

Cutera, Inc. is headquartered in US.

Cutera, Inc. (CUTR) stock trades at $0.10 with a market capitalization of $1.96M. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.01, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.01 and $3.00, and currently trades 96.7% below its 52-week high.

On profitability, Cutera, Inc. generates a return on equity (ROE) of 174.14% — well above the market average, a sign of a high-quality business, return on capital employed of -60.43%, an operating margin of -73.57%, a net profit margin of -76.67%.

Official website: www.cutera.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides